Head & Neck Cancer | Tumor

Marijuana Impacts the Progression of HPV Related Head and Neck Squamous Cell Carcinoma

January 24th 2020, 3:00am


Marijuana is often linked to fighting cancer and its effects, but in the case of head and neck squamous cell carcinoma, researchers found that it may increase the progression of the disease.

Triumph Begins With U

January 18th 2020, 9:00pm


Mona P is finding hope, life and healing after carcinoma of the pharynx.

FDA Steps Up Review of Tipifarnib for Treatment of Certain Patients with Head and Neck Cancer

December 17th 2019, 2:13am


Fast track designation has been granted for the investigational therapy tipifarnib to treat patients with HRAS mutant head and neck squamous cell carcinomas.

Acupuncture as a Complementary Therapy During Radiation Treatment Can Reduce Dry Mouth

December 16th 2019, 9:15pm


Patients with head and neck cancer who received acupuncture during therapy saw lower incidence and severity of dry mouth compared with those who received oral health education.

Patients With Head and Neck Cancer Could See Benefit from Investigational Therapy

November 14th 2019, 1:00am


The investigational agent tipifarnib shows promise in patients with head and neck cancer who have a certain gene mutation.

Carpe Diem

October 29th 2019, 7:00pm


SupermanHPV: Fighting Against HPV-Related Cancers

August 22nd 2019, 5:00pm


In this episode of the “CURE Talks Cancer” podcast, we spoke with Jason Mendelsohn, a stage 4 HPV-related throat cancer survivor who created a web site geared to raising awareness about HPV-related cancers.

Drumming Out Head and Neck Cancer

August 12th 2019, 8:38pm


Poison’s Rikki Rockett discusses the immunotherapy clinical trial that led him into remission.

Cancer Caregivers Need Support, Too

August 1st 2019, 4:00pm


In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a caregiver about support for others taking care of a loved one with cancer through a letter she wrote to her younger self.

FDA Approves Keytruda to Treat Esophageal Squamous Cell Carcinoma

July 31st 2019, 5:51pm


The Food and Drug Administration has approved Keytruda for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus in certain patients.